This trial is being conducted to study the efficacy of the ipilimumab, nivolumab, and radiation therapy in microsatellite stable pancreatic cancer patients.
1 Primary · 4 Secondary · Reporting Duration: Up to 5 years
Experimental Treatment
30 Total Participants · 1 Treatment Group
Primary Treatment: Ipilimumab · No Placebo Group · Phase 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: